SCHEMBL7269182

SCHEMBL7269182

CC(C)C[C@H](CC(=O)N(C)Cc1ccccc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.57
▸ RAB9A P51151 3/20 0.57
▸ KMT2A Q03164 3/20 0.53
▸ HPGD P15428 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ CA12 O43570 1/20 0.49
▸ CA9 Q16790 1/20 0.49
▸ ANPEP P15144 1/20 0.48
▸ RNPEP Q9H4A4 1/20 0.48
▸ DNPEP Q9ULA0 1/20 0.48
▸ TACR1 P25103 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ LMNA P02545 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7274920 0.85 CPA1 (0.60) NPC1RAB9AKMT2AHPGDTDP1
SCHEMBL14073880 0.84 NPC1 (0.68) NPC1RAB9AKMT2AHPGDTDP1
SCHEMBL8539168 0.79 PSMB1 (0.50) NPC1RAB9AHPGD
SCHEMBL7270627 0.79 PSMB1 (0.49) NPC1RAB9AKMT2AHPGDCA12
SCHEMBL8654060 0.79 POLQ (0.44) KMT2ASMN1; SMN2ANPEPRNPEPDNPEP
SCHEMBL8304512 0.76 NPC1 (0.66) NPC1RAB9AKMT2AHPGDTDP1
SCHEMBL7277271 0.76 TDP1 (0.69) NPC1RAB9AKMT2ATDP1SMN1; SMN2
SCHEMBL7269002 0.75 MMP2 (0.45) NPC1RAB9AKMT2ATDP1TACR1
SCHEMBL19573455 0.75 NPC1 (0.74) NPC1RAB9AKMT2AHPGDSMN1; SMN2
SCHEMBL7310334 0.75 NPC1 (0.48) NPC1RAB9AKMT2AHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 — — EP disclosed
US-5670675-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-09-23 — — US disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 — — US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 — — US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 — — EP disclosed
Send feedback